the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

View All Categories
View Conferences

Antibody & Immunity Market Research Reports

 

We offer market research, industry forecasts, and business analysis in the Antibody & Immunity Market as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis. The easiest way to find out if we have the information you need is to contact us right now. We are open 24 hours a day, 5 days a week with multiple language support. Please see our Contact page to see which office is open right now.

 
 
Antibiotic Resistance and Antibiotic Technologies: Global Markets
Table of Contents Published: 2009/11 Published by: BCC Research
The scope of this report includes current antibiotic markets as well as the emerging antibiotic market, with an exclusive focus on antibiotic resistance. It technically encompasses antibacterials that include antibiotics, bacterial vaccines, and other eme ...

Monoclonal Antibodies: 2009 update
Table of Contents Published: 2009/11 Published by: Datamonitor
The report provides a comprehensive financial and strategic analysis of the mAb market, forecasting its commercial evolution out to 2014 and assessing trends by product, company, therapy area, geography, technology and target type. It also provides an ins ...

Antiviral Therapeutics - technologies, markets and companies
Table of Contents Published: 2009/11 Published by: Jain Pharmabiotech
This report reviews the current state-of-art of antiviral approaches including vaccines, pharmaceuticals and innovative technologies for delivery of therapeutics. The introduction starts with a practical classification of viral diseases according to their ...

Immunotherapies and Vaccines for Nontraditional Indications
Table of Contents Published: 2009/10 Published by: Insight Pharma Reports
This report: Covers a wide range of conditions for which immunotherapies may be effective, including Alzheimer' s disease, addiction, other neurological indications, cardiovascular diseases, hematological disorders, ophthalmic diseases, bone metabolism di ...

Blood Typing, Grouping and Infectious Disease Screening Tests:Analysis of Current and Emerging Assays and Companies Developing New Technologies and Products
Table of Contents Published: 2009/09 Published by: Venture Planning Group
The report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing n ...

Monoclonal Antibody Therapeutics 2009-2024
Table of Contents Published: 2009/08 Published by: Visiongain
Monoclonal antibodies achieved total sales of nearly $32bn in 2008 and have grown rapidly to command over 30% of the global biologic drug market. We expect significant opportunities for further commercial growth from 2009 to 2024, as shown in our new repo ...

Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment Overview
Table of Contents Published: 2009/08 Published by: Insight Pharma Reports
Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment presents an analysis for the current state of mAb drug development. It identifies more than 250 therapeutic products now in clinical trials, which are largely concentrated in the areas of ...

Dealmaking and Industry Outlook: Autoimmune and Inflammatory Diseases
Table of Contents Published: 2009/07 Published by: Decision Resources, Inc.
Better diagnostics, the means to treat earlier stage-disease, disease-modifying therapies, and disease prevention are the holy grails of autoimmune and infl ammatory disease drug development. However, basic science and redundant biological pathways are ho ...

Therapeutic Monoclonal Antibodies Markets
Table of Contents Published: 2009/06 Published by: Trimark Publications
Antibodies are proteins in the immune system that help the body defend against foreign invasion, particularly from pathogens and toxins. As such, a human-engineered therapeutic monoclonal antibody (mAb) is protein derived from the immune system through re ...

Monoclonal Antibodies in Cancer Therapy 2009-2024
Table of Contents Published: 2009/05 Published by: Visiongain
Monoclonal antibody-based therapies for cancer are a thriving part of the biotechnology sector, as our new market report explains. The oncology market continues to expand worldwide, with high demand for more-efficacious and better-tolerated cancer therapi ...

The Market for Antibodies: Keys to Success for Commercial Suppliers, Vol. III
Table of Contents Published: 2009/05 Published by: BioInformatics, LLC
The Market for Antibodies: Keys to Success for Commercial Suppliers, Volume III will help suppliers better understand how antibodies are used and how demand is impacted by scientific application. In addition, segmentation analysis and trend comparisons wi ...

Dealmaking and Industry Outlook: Antivirals
Table of Contents Published: 2009/05 Published by: Decision Resources, Inc.
The infamous mutability of viruses has long challenged antiviral drug developers, but complete genome sequences are now known for thousands of viruses, and the viral proteins encoded in these sequences are being used as targets for novel antiviral develop ...

Dealmaking and Industry Outlook: Therapeutic Antibodies and Vaccines for Cancer
Table of Contents Published: 2009/04 Published by: Decision Resources, Inc.
Targeted cancer therapies have achieved phenomenal growth, and many MAb-based immunotherapies are blockbusters or mega-blockbusters. This market success is due not only to these MAbs' ability to treat unmet need in many cancers but also to the high cost o ...

Rituxan Case Study: Pre-Launch Communications to Change the Dominant Treatment Paradigm
Table of Contents Published: 2009/02 Published by: Best Practices, LLC
This case study reviews the strategy and tactics utilized by Genentech for the Rheumatoid Arthritis (RA) indicated product, Rituxan, to communicate with KOLs regarding a new mechanism of action treatment for moderate-to-severe RA. The company started by u ...

Immunotherapy in Oncology: Drug Pipeline Update 2009
Table of Contents Published: 2009/01 Published by: BioSeeker Group AB
Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. In this Drug Pipeline Update BioSeeker brings together the fields of antibodies, vaccines, and immunostimulators ...

Antibodies in Oncology: Drug Pipeline Update 2009
Table of Contents Published: 2009/01 Published by: BioSeeker Group AB
The commercial and therapeutic success of antibodies like Rituxan, Avastin, and Erbitux will force the industry to look into the next generation of therapeutic antibodies, preparing themselves for the second wave in the lucrative field of therapeutic anti ...

Immunotherapies and Vaccines for Cancer and Infectious Diseases Report
Table of Contents Published: 2008/10 Published by: Insight Pharma Reports
Immunotherapies and Vaccines for Cancer and Infectious Diseases reviews current pharmacological options for 12 major cancers being targeted by companies developing cancer immunotherapies or vaccines. While a large number of drugs are available for these p ...

Strategic Analysis of the European Immunoassay Market
Table of Contents Published: 2008/10 Published by: Frost & Sullivan
This research service analyses the market scenario for immunoassays in laboratory and POC setting for major seven European countries. It analyses the market trends, market landscape,competitive strategies along with market drivers,restraints and challenge ...

Global Antivirals Market Analysis & Forecasts 2008-2023
Table of Contents Published: 2008/09 Published by: Visiongain
Investors are turning their attention to antiviral drug discovery because there is a renewed recognition of the promising opportunities in this $20bn market. Twenty years from the inception of focused antiviral drug research, there are 8 blockbuster drugs ...

European Therapeutic Monoclonal Antibody Markets
Table of Contents Published: 2008/08 Published by: Frost & Sullivan
This research service analyses the market landscape, revenue potential, market dynamics and trends in the monocloanl antibodies market focussing on five major markets in Europe. ...

Therapeutic Monoclonal Antibodies Report 2008-2023
Table of Contents Published: 2008/07 Published by: Visiongain
This brand new report investigates the global market for therapeutic monoclonal antibodies. While the pharmaceutical industry as a whole is suffering from single digit growth, thinner pipelines than before and pressure from an ever-aggressive generics ind ...

Antibiotic R&D: Resolving the Paradox between Unmet Medical Need and Commercial Incentive
Table of Contents Published: 2008/07 Published by: Insight Pharma Reports
The current crisis in antibiotic R&D is attributed to an industry pipeline with few late-stage candidates capable of combating the emergence and spread of novel, drug-resistant bacterial strains. ...

U.S. and Worldwide Monoclonal Antibody Medicine
Table of Contents Published: 2008/07 Published by: Fuji-Keizai U.S.A., Inc.
This report analyzes the activities of the leading biopharmaceutical companies with antibody-based drug products currently on the market or scheduled for introduction soon. The focus is MAb therapeutics used for treating a disease or condition (as opposed ...

Cancer Antibodies: Competitive Positioning for Success
Table of Contents Published: 2008/06 Published by: BioSeeker Group AB
This report aims to analyze the current and future potential of cancer antibodies by examining key fundamentals across the entire pipeline of antibody drug candidates. ...

Chinese Markets for Cephalosporins
Table of Contents Published: 2008/06 Published by: Asia Market Information & Development Co.
China' s demand for Cephalosporins has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry development, suppl ...

U.S. Biotechnology - Therapeutic Monoclonal Antibodies Market
Table of Contents Published: 2008/05 Published by: Frost & Sullivan
This research service covers the U.S. biotechnology: therapeutic monoclonal antibodies market from 2004-2014. Included are a disease overviews, technology trends, total market revenue forecasts, market segment revenue forecasts, and market share analysis. ...

Antibiotics
Table of Contents Published: 2008/05 Published by: Global Industry Analysts, Inc.
This report analyzes the worldwide markets for Antibiotics in US$ Billion. The Major product segments Analyzed are Penicillin, Cephalosporins, Macrolides, Quinolones, Carbapenems, and Other Antibiotics (Aminoglycosides, Tetracyclines, Sulfonamides, Mupiro ...

The Deployment of Antibody Technologies for the Advancement of Cancer Therapeutics
Table of Contents Published: 2008/04 Published by: BioSeeker Group AB
The discovery of new cancer therapeutics has seen a significant shift towards biologicals as an alternative to small molecule drugs. ...

Stakeholder Opinions: Biologics in Infectious Diseases - Well defined target populations are key to commercial success
Table of Contents Published: 2008/03 Published by: Datamonitor
This report provides Biologics in Infectious Diseases Stakeholder Opinions Market Research, Trends, Analysis. ...

Biologics Pipelines: Who Has the Next Promising Monoclonal Antibodies?
Table of Contents Published: 2008/03 Published by: Decision Resources, Inc.
Monoclonal antibodies (MAbs) are very hot commodities in today' s pharmaceutical marketplace, and in recent years, the growth in the number of MAbs under development has far outpaced the growth of other types of drugs. ...

Cancer Cell Therapy Markets
Table of Contents Published: 2008/03 Published by: Trimark Publications
Traditionally, treatment of disease is carried out by small molecules that target specific cell types. In diseases such as cancer, the treatment is meant to kill cancer cells, leading to the removal or at least the inhibition of cancer cell proliferation. ...

Antibiotics and Drug Resistance 2008
Table of Contents Published: 2008/01 Published by: BioPharm Reports (Technology and Markets Ltd)
This report reviews new drug innovation and strategy to combat antibiotic resistance mechanisms. This embraces current research-stage activities, patents published in the last five years, the entire pharmaceutical development pipeline and today' s existin ...

Monoclonal Therapeutics and Companion Diagnostic Products
Table of Contents Published: 2008/01 Published by: BCC Research
Our key objective was to present a comprehensive analysis of the current monoclonal antibody market and its future direction. ...

Global Immunochemicals Markets
Table of Contents Published: 2008/01 Published by: Frost & Sullivan
This research service analyses the market landscape, challenges, drivers, restraints and opportunities for the global immunochemicals market. ...

European Immunochemistry Analysers Markets
Table of Contents Published: 2008/01 Published by: Frost & Sullivan
This study contains the market trends, revenue forecasts, geographical Analysis, technology trends, geographic trends, end user trends and competitive Analysis. ...

Antibody Drug Targets and Special Focus on Leukemias & Lymphomas
Table of Contents Published: 2007/12 Published by: BioSeeker Group AB
In this triple analysis report BioSeeker Group has analyzed three major and intertwined areas of cancer R&D, Antibody drug target, Leukemias and Lymphomas, which are all subjects to an extensive number of innovative drug candidates. This extensive 430+ pa ...

Next-Generation Biologics: Improving on Monoclonal Antibodies
Table of Contents Published: 2007/12 Published by: Decision Resources, Inc.
Monoclonal antibodies (MAbs) have become the most successful platform for targeted biotherapeutics, demonstrating high affi nity and specifi city for their target and considerably lower toxicity than small-molecule drugs. ...

Antibody Drug Targets and Focus on Breast- & Prostate Cancer
Table of Contents Published: 2007/11 Published by: BioSeeker Group AB
In this triple analysis report BioSeeker Group has analyzed three major and intertwined areas of cancer R&D, Antibody drug target, Breast- and Prostate cancer, which are all subjects to an extensive number of innovative drug candidates. This extensive 380 ...

Monoclonal Antibodies Report Part II: Companies - Holding mAbs in portfolio promises protection against the looming 2011-12 patent cliff
Table of Contents Published: 2007/09 Published by: Datamonitor
NICE is one of the most advanced cost effectiveness assessment bodies operating in the major pharmaceutical markets. Since it was established it has had an increasing impact on the availability of new drugs in England and Wales, but has also generated con ...

Building on Early Successes of Immunomodulators in the Fight Against Cancer
Table of Contents Published: 2007/09 Published by: Decision Resources, Inc.
Although no immunotherapies have yet emerged to fulfill immunologists' decades-long hope of developing safe, highly effective, tumor-specific immunotherapies, the field of nonspecific immunomodulatory drugs is enjoying modest success. ...

Substances and finished pharmaceutical products of antibiotics: market research in Russia
Table of Contents Published: 2007/08 Published by: INFOMINE Research Group
The report is devoted to analysis of current standing of production of substances and finished pharmaceutical products of medicinal antibiotics in Russia. ...

Triple Analysis: Antibody Drug Target Atlas in Oncology and Special Focus on Melanoma and NSCLC
Table of Contents Published: 2007/07 Published by: BioSeeker Group AB
In this triple analysis report BioSeeker Group has analyzed three major and intertwined areas of cancer R&D, Antibody drug targets, Melanoma, and NSCLC, which are all subjects to an extensive number of innovative drug candidates. ...

Monoclonal Antibodies Report Part I
Table of Contents Published: 2007/06 Published by: Datamonitor
The report provides a comprehensive financial and strategic analysis of the mAb market, forecasting its commercial evolution out to 2012 and assessing trends by product, company, therapy area, technology and target type. It also provides an insight into t ...

Antibody Drug Target Atlas in Oncology
Table of Contents Published: 2007/06 Published by: BioSeeker Group AB
The elaborate advances towards the blueprinting of the altered molecular networks that lie behind cancer development have paved the way for targeted therapy in cancer. ...

The Global Antivirals Market - R&D Pipelines, Market Analysis and Competitive Landscape
Table of Contents Published: 2007/05 Published by: Arrowhead Publishers
This report examines each of the antiviral classes in turn, assessing the market potential and encompassing the major infectious diseases to which they are applicable. ...

Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments: World Market
Table of Contents Published: 2007/05 Published by: Kalorama Information
This report provides Monoclonal Antibodies, Vaccines & Immunologic Cancer Treatments Market Research, Trends, Analysis. ...

Monoclonal Antibodies: what the future holds
Table of Contents Published: 2007/04 Published by: Espicom Business Intelligence
This new management report covers 30 leading compounds and is essential reading for everyone working in the field. ...

Are Biologics the Wave of the Future?
Table of Contents Published: 2007/03 Published by: Decision Resources, Inc.
Biologics have been good to the pharmaceutical industry- a trend that will continue for the foreseeable future as a raft of new and improved biologics comes to market. Some companies rode the crest of the biologics wave that began 25 years ago while other ...

Immunotherapy of Cancer
Table of Contents Published: 2007/03 Published by: BCC Research
This report provides Cancer Immunotherapy Market Research, Trends, Analysis. ...

Global Markets for Antifungal Agents
Table of Contents Published: 2007/03 Published by: BCC Research
This report provides Antifungal Agents Market Research Trends, Analysis. ...


US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.